This code represents an elevated prostate-specific antigen (PSA) level. PSA is a protein produced by the prostate gland, and its level can be measured in a blood test. Elevated PSA levels can be an indicator of prostate cancer, but they can also be caused by other conditions, such as benign prostatic hyperplasia (BPH) and prostatitis.
This code is used when a patient has an elevated PSA level, and the reason for the elevation is not yet determined. It is important to note that this code is not a diagnosis of prostate cancer. Further investigation and clinical evaluation are required to determine the cause of the elevated PSA.
Important Notes:
This code should not be used if the reason for the elevated PSA is known.
Further investigation and diagnosis are necessary to determine the underlying cause of the elevated PSA.
Clinical Scenarios:
This code is used when a patient presents with an elevated PSA level. Here are several common scenarios: 1. Initial Screening - A 55-year-old male patient presents for his annual physical exam. As part of the routine screening, a PSA test is ordered. - The test result shows an elevated PSA level. - R97.20 would be used to code this finding. The doctor will order further investigations, such as a biopsy, to determine the cause of the elevated PSA. 2. Follow-up Screening - A 62-year-old male patient with a history of BPH is undergoing regular PSA monitoring. - His PSA level is found to be slightly elevated, but there are no other symptoms. - R97.20 would be used to code this finding. The doctor may choose to repeat the PSA test in a few months or order further diagnostic testing. 3. Symptomatic Patient - A 70-year-old male patient presents with urinary frequency and difficulty starting urination. - A PSA test is ordered and reveals a significantly elevated level. - R97.20 is used to code the finding, but because the patient has urinary symptoms, a more extensive evaluation will be required. The doctor will likely recommend a prostate biopsy.
Code Category and Dependencies
R97.20 falls under the code category: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified > Abnormal tumor markers.
Accurate coding of R97.20 is essential, and it should be used in conjunction with related CPT, HCPCS, and ICD-10-CM codes. These codes are crucial for accurate documentation of services and for billing purposes.
Here are some of the dependencies:
- CPT Codes: CPT codes describe procedures and services. In the case of PSA testing, these could include: - 84153: Prostate-specific antigen [PSA]; total. - 84154: Prostate-specific antigen [PSA]; free. - 81313: PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer).
- HCPCS Codes: HCPCS codes are used for supplies, equipment, and other services. A relevant code for PSA testing would be: - G0103: Prostate cancer screening; prostate-specific antigen test (PSA).
- ICD-10-CM Codes: These codes provide specific information on diseases, symptoms, and other medical conditions. Examples relevant to elevated PSA include: - R97: Abnormal tumor markers. - N41: Benign prostatic hyperplasia. - N41.1: Benign prostatic hyperplasia with lower urinary tract symptoms. - N41.2: Benign prostatic hyperplasia without lower urinary tract symptoms.
- DRG Codes: DRG (Diagnosis-Related Groups) codes are used for grouping similar patients for reimbursement purposes. This code can potentially affect the assignment of several DRGs, particularly in the “Signs and Symptoms” DRGs, such as 947 (SIGNS AND SYMPTOMS WITH MCC) and 948 (SIGNS AND SYMPTOMS WITHOUT MCC).
Important note: Using the wrong codes can have legal and financial consequences, so coders should always ensure they are using the latest versions of these codes. It is vital that medical coders use their best judgment and remain up-to-date with changes in coding guidelines and practices.